nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—Decreased Blood Pressure—Enalapril—coronary artery disease	0.269	1	CiPCiCtD
Azilsartan medoxomil—AGTR1—coronary artery disease	0.107	1	CbGaD
Azilsartan medoxomil—Telmisartan—coronary artery disease	0.104	0.4	CrCtD
Azilsartan medoxomil—Olmesartan—coronary artery disease	0.0858	0.331	CrCtD
Azilsartan medoxomil—Losartan—coronary artery disease	0.0696	0.269	CrCtD
Azilsartan medoxomil—AGTR1—Olmesartan—coronary artery disease	0.0503	0.331	CbGbCtD
Azilsartan medoxomil—AGTR1—Telmisartan—coronary artery disease	0.0402	0.264	CbGbCtD
Azilsartan medoxomil—AGTR1—Valsartan—coronary artery disease	0.0391	0.257	CbGbCtD
Azilsartan medoxomil—AGTR1—Losartan—coronary artery disease	0.0225	0.148	CbGbCtD
Azilsartan medoxomil—Telmisartan—Olmesartan—coronary artery disease	0.0161	0.0978	CrCrCtD
Azilsartan medoxomil—Olmesartan—Telmisartan—coronary artery disease	0.0134	0.0811	CrCrCtD
Azilsartan medoxomil—Telmisartan—Losartan—coronary artery disease	0.0131	0.0794	CrCrCtD
Azilsartan medoxomil—Tasosartan—Olmesartan—coronary artery disease	0.0123	0.0747	CrCrCtD
Azilsartan medoxomil—Losartan—Telmisartan—coronary artery disease	0.0122	0.0738	CrCrCtD
Azilsartan medoxomil—Tasosartan—Valsartan—coronary artery disease	0.0118	0.0713	CrCrCtD
Azilsartan medoxomil—Candesartan—Telmisartan—coronary artery disease	0.0112	0.0678	CrCrCtD
Azilsartan medoxomil—Olmesartan—Valsartan—coronary artery disease	0.0106	0.0641	CrCrCtD
Azilsartan medoxomil—Losartan—Olmesartan—coronary artery disease	0.0101	0.0611	CrCrCtD
Azilsartan medoxomil—Tasosartan—Losartan—coronary artery disease	0.00999	0.0606	CrCrCtD
Azilsartan medoxomil—Losartan—Valsartan—coronary artery disease	0.00961	0.0583	CrCrCtD
Azilsartan medoxomil—Candesartan—Olmesartan—coronary artery disease	0.00926	0.0562	CrCrCtD
Azilsartan medoxomil—Olmesartan—Losartan—coronary artery disease	0.00898	0.0545	CrCrCtD
Azilsartan medoxomil—Candesartan—Valsartan—coronary artery disease	0.00884	0.0536	CrCrCtD
Azilsartan medoxomil—Candesartan—Losartan—coronary artery disease	0.00751	0.0456	CrCrCtD
Azilsartan medoxomil—AGTR1—artery—coronary artery disease	0.000838	0.236	CbGeAlD
Azilsartan medoxomil—AGTR1—endothelium—coronary artery disease	0.000708	0.199	CbGeAlD
Azilsartan medoxomil—AGTR1—cardiac ventricle—coronary artery disease	0.00047	0.132	CbGeAlD
Azilsartan medoxomil—AGTR1—myocardium—coronary artery disease	0.000442	0.124	CbGeAlD
Azilsartan medoxomil—AGTR1—heart—coronary artery disease	0.000309	0.0869	CbGeAlD
Azilsartan medoxomil—AGTR1—cardiovascular system—coronary artery disease	0.000291	0.082	CbGeAlD
Azilsartan medoxomil—AGTR1—cardiac atrium—coronary artery disease	0.000264	0.0743	CbGeAlD
Azilsartan medoxomil—AGTR1—blood—coronary artery disease	0.00023	0.0648	CbGeAlD
Azilsartan medoxomil—Tasosartan—AGTR1—coronary artery disease	0.000171	0.195	CrCbGaD
Azilsartan medoxomil—Olmesartan—AGTR1—coronary artery disease	0.000144	0.165	CrCbGaD
Azilsartan medoxomil—Telmisartan—AGTR1—coronary artery disease	0.000139	0.159	CrCbGaD
Azilsartan medoxomil—Candesartan—AGTR1—coronary artery disease	0.000112	0.128	CrCbGaD
Azilsartan medoxomil—Telmisartan—PPARG—coronary artery disease	8.75e-05	0.1	CrCbGaD
Azilsartan medoxomil—Losartan—AGTR1—coronary artery disease	7.22e-05	0.0826	CrCbGaD
Azilsartan medoxomil—Skin disorder—Eplerenone—coronary artery disease	6.25e-05	0.00235	CcSEcCtD
Azilsartan medoxomil—Pruritus—Ticagrelor—coronary artery disease	6.22e-05	0.00234	CcSEcCtD
Azilsartan medoxomil—Angioedema—Trandolapril—coronary artery disease	6.16e-05	0.00232	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Gemfibrozil—coronary artery disease	6.16e-05	0.00232	CcSEcCtD
Azilsartan medoxomil—Angioedema—Enalapril—coronary artery disease	6.14e-05	0.00231	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Valsartan—coronary artery disease	6.13e-05	0.00231	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Losartan—coronary artery disease	6.12e-05	0.0023	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—coronary artery disease	6.11e-05	0.0023	CcSEcCtD
Azilsartan medoxomil—Angioedema—Telmisartan—coronary artery disease	6.06e-05	0.00228	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Perindopril—coronary artery disease	6.02e-05	0.00226	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Ticagrelor—coronary artery disease	6.01e-05	0.00226	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Niacin—coronary artery disease	5.97e-05	0.00224	CcSEcCtD
Azilsartan medoxomil—Dizziness—Gemfibrozil—coronary artery disease	5.95e-05	0.00224	CcSEcCtD
Azilsartan medoxomil—Telmisartan—CYP2C19—coronary artery disease	5.94e-05	0.0679	CrCbGaD
Azilsartan medoxomil—Gastrointestinal disorder—Fenofibrate—coronary artery disease	5.93e-05	0.00223	CcSEcCtD
Azilsartan medoxomil—Fatigue—Fenofibrate—coronary artery disease	5.92e-05	0.00223	CcSEcCtD
Azilsartan medoxomil—Angioedema—Captopril—coronary artery disease	5.89e-05	0.00221	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Furosemide—coronary artery disease	5.85e-05	0.0022	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Clopidogrel—coronary artery disease	5.83e-05	0.00219	CcSEcCtD
Azilsartan medoxomil—Fatigue—Clopidogrel—coronary artery disease	5.82e-05	0.00219	CcSEcCtD
Azilsartan medoxomil—Dizziness—Ticagrelor—coronary artery disease	5.81e-05	0.00219	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Valsartan—coronary artery disease	5.81e-05	0.00218	CcSEcCtD
Azilsartan medoxomil—Fatigue—Lovastatin—coronary artery disease	5.78e-05	0.00217	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Olmesartan—coronary artery disease	5.78e-05	0.00217	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Valsartan—coronary artery disease	5.75e-05	0.00216	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Olmesartan—coronary artery disease	5.72e-05	0.00215	CcSEcCtD
Azilsartan medoxomil—Angioedema—Perindopril—coronary artery disease	5.72e-05	0.00215	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—coronary artery disease	5.7e-05	0.00215	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Ramipril—coronary artery disease	5.69e-05	0.00214	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Ramipril—coronary artery disease	5.68e-05	0.00214	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Ezetimibe—coronary artery disease	5.68e-05	0.00214	CcSEcCtD
Azilsartan medoxomil—Asthenia—Rosuvastatin—coronary artery disease	5.68e-05	0.00213	CcSEcCtD
Azilsartan medoxomil—Rash—Gemfibrozil—coronary artery disease	5.67e-05	0.00213	CcSEcCtD
Azilsartan medoxomil—Fatigue—Ezetimibe—coronary artery disease	5.67e-05	0.00213	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Gemfibrozil—coronary artery disease	5.67e-05	0.00213	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Losartan—coronary artery disease	5.64e-05	0.00212	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	5.6e-05	0.00211	CcSEcCtD
Azilsartan medoxomil—Pruritus—Rosuvastatin—coronary artery disease	5.6e-05	0.00211	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Niacin—coronary artery disease	5.59e-05	0.0021	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Timolol—coronary artery disease	5.57e-05	0.00209	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Eplerenone—coronary artery disease	5.56e-05	0.00209	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Timolol—coronary artery disease	5.55e-05	0.00209	CcSEcCtD
Azilsartan medoxomil—Fatigue—Eplerenone—coronary artery disease	5.55e-05	0.00209	CcSEcCtD
Azilsartan medoxomil—Rash—Ticagrelor—coronary artery disease	5.54e-05	0.00208	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Ticagrelor—coronary artery disease	5.54e-05	0.00208	CcSEcCtD
Azilsartan medoxomil—Pruritus—Acetylsalicylic acid—coronary artery disease	5.44e-05	0.00205	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Simvastatin—coronary artery disease	5.41e-05	0.00204	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Rosuvastatin—coronary artery disease	5.41e-05	0.00204	CcSEcCtD
Azilsartan medoxomil—Fatigue—Simvastatin—coronary artery disease	5.41e-05	0.00203	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Trandolapril—coronary artery disease	5.4e-05	0.00203	CcSEcCtD
Azilsartan medoxomil—Angioedema—Losartan—coronary artery disease	5.36e-05	0.00202	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Trandolapril—coronary artery disease	5.35e-05	0.00201	CcSEcCtD
Azilsartan medoxomil—Nausea—Gemfibrozil—coronary artery disease	5.34e-05	0.00201	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Telmisartan—coronary artery disease	5.3e-05	0.00199	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	5.29e-05	0.00199	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Acetylsalicylic acid—coronary artery disease	5.26e-05	0.00198	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Telmisartan—coronary artery disease	5.25e-05	0.00198	CcSEcCtD
Azilsartan medoxomil—Dizziness—Rosuvastatin—coronary artery disease	5.23e-05	0.00197	CcSEcCtD
Azilsartan medoxomil—Nausea—Ticagrelor—coronary artery disease	5.22e-05	0.00196	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Lisinopril—coronary artery disease	5.16e-05	0.00194	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	5.14e-05	0.00193	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Timolol—coronary artery disease	5.13e-05	0.00193	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Valsartan—coronary artery disease	5.11e-05	0.00192	CcSEcCtD
Azilsartan medoxomil—Fatigue—Valsartan—coronary artery disease	5.11e-05	0.00192	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Olmesartan—coronary artery disease	5.09e-05	0.00191	CcSEcCtD
Azilsartan medoxomil—Dizziness—Acetylsalicylic acid—coronary artery disease	5.08e-05	0.00191	CcSEcCtD
Azilsartan medoxomil—Fatigue—Olmesartan—coronary artery disease	5.08e-05	0.00191	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Perindopril—coronary artery disease	5.01e-05	0.00188	CcSEcCtD
Azilsartan medoxomil—Rash—Rosuvastatin—coronary artery disease	4.99e-05	0.00188	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Rosuvastatin—coronary artery disease	4.98e-05	0.00187	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Niacin—coronary artery disease	4.97e-05	0.00187	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Perindopril—coronary artery disease	4.96e-05	0.00187	CcSEcCtD
Azilsartan medoxomil—Asthenia—Fenofibrate—coronary artery disease	4.93e-05	0.00185	CcSEcCtD
Azilsartan medoxomil—Fatigue—Pravastatin—coronary artery disease	4.89e-05	0.00184	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Furosemide—coronary artery disease	4.87e-05	0.00183	CcSEcCtD
Azilsartan medoxomil—Pruritus—Fenofibrate—coronary artery disease	4.86e-05	0.00183	CcSEcCtD
Azilsartan medoxomil—Rash—Acetylsalicylic acid—coronary artery disease	4.85e-05	0.00182	CcSEcCtD
Azilsartan medoxomil—Asthenia—Clopidogrel—coronary artery disease	4.84e-05	0.00182	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Acetylsalicylic acid—coronary artery disease	4.84e-05	0.00182	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Ramipril—coronary artery disease	4.84e-05	0.00182	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Furosemide—coronary artery disease	4.82e-05	0.00181	CcSEcCtD
Azilsartan medoxomil—Asthenia—Lovastatin—coronary artery disease	4.81e-05	0.00181	CcSEcCtD
Azilsartan medoxomil—Pruritus—Clopidogrel—coronary artery disease	4.77e-05	0.0018	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Lisinopril—coronary artery disease	4.76e-05	0.00179	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Trandolapril—coronary artery disease	4.75e-05	0.00179	CcSEcCtD
Azilsartan medoxomil—Fatigue—Trandolapril—coronary artery disease	4.75e-05	0.00179	CcSEcCtD
Azilsartan medoxomil—Pruritus—Lovastatin—coronary artery disease	4.74e-05	0.00178	CcSEcCtD
Azilsartan medoxomil—Fatigue—Enalapril—coronary artery disease	4.73e-05	0.00178	CcSEcCtD
Azilsartan medoxomil—Asthenia—Ezetimibe—coronary artery disease	4.72e-05	0.00177	CcSEcCtD
Azilsartan medoxomil—Nausea—Rosuvastatin—coronary artery disease	4.7e-05	0.00177	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Fenofibrate—coronary artery disease	4.7e-05	0.00177	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Losartan—coronary artery disease	4.7e-05	0.00177	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Telmisartan—coronary artery disease	4.67e-05	0.00176	CcSEcCtD
Azilsartan medoxomil—Fatigue—Telmisartan—coronary artery disease	4.66e-05	0.00175	CcSEcCtD
Azilsartan medoxomil—Pruritus—Ezetimibe—coronary artery disease	4.65e-05	0.00175	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Clopidogrel—coronary artery disease	4.62e-05	0.00174	CcSEcCtD
Azilsartan medoxomil—Asthenia—Eplerenone—coronary artery disease	4.62e-05	0.00174	CcSEcCtD
Azilsartan medoxomil—Angioedema—Ramipril—coronary artery disease	4.6e-05	0.00173	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Lovastatin—coronary artery disease	4.59e-05	0.00173	CcSEcCtD
Azilsartan medoxomil—Nausea—Acetylsalicylic acid—coronary artery disease	4.56e-05	0.00172	CcSEcCtD
Azilsartan medoxomil—Pruritus—Eplerenone—coronary artery disease	4.55e-05	0.00171	CcSEcCtD
Azilsartan medoxomil—Dizziness—Fenofibrate—coronary artery disease	4.54e-05	0.00171	CcSEcCtD
Azilsartan medoxomil—Fatigue—Captopril—coronary artery disease	4.53e-05	0.00171	CcSEcCtD
Azilsartan medoxomil—Asthenia—Simvastatin—coronary artery disease	4.5e-05	0.00169	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Ezetimibe—coronary artery disease	4.5e-05	0.00169	CcSEcCtD
Azilsartan medoxomil—Angioedema—Timolol—coronary artery disease	4.49e-05	0.00169	CcSEcCtD
Azilsartan medoxomil—Dizziness—Clopidogrel—coronary artery disease	4.46e-05	0.00168	CcSEcCtD
Azilsartan medoxomil—Pruritus—Simvastatin—coronary artery disease	4.44e-05	0.00167	CcSEcCtD
Azilsartan medoxomil—Dizziness—Lovastatin—coronary artery disease	4.43e-05	0.00167	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Perindopril—coronary artery disease	4.41e-05	0.00166	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Eplerenone—coronary artery disease	4.4e-05	0.00166	CcSEcCtD
Azilsartan medoxomil—Fatigue—Perindopril—coronary artery disease	4.4e-05	0.00166	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Lisinopril—coronary artery disease	4.39e-05	0.00165	CcSEcCtD
Azilsartan medoxomil—Dizziness—Ezetimibe—coronary artery disease	4.35e-05	0.00164	CcSEcCtD
Azilsartan medoxomil—Rash—Fenofibrate—coronary artery disease	4.33e-05	0.00163	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Fenofibrate—coronary artery disease	4.33e-05	0.00163	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Simvastatin—coronary artery disease	4.29e-05	0.00161	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Furosemide—coronary artery disease	4.29e-05	0.00161	CcSEcCtD
Azilsartan medoxomil—Fatigue—Furosemide—coronary artery disease	4.28e-05	0.00161	CcSEcCtD
Azilsartan medoxomil—Dizziness—Eplerenone—coronary artery disease	4.26e-05	0.0016	CcSEcCtD
Azilsartan medoxomil—Rash—Clopidogrel—coronary artery disease	4.26e-05	0.0016	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	4.25e-05	0.0016	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Clopidogrel—coronary artery disease	4.25e-05	0.0016	CcSEcCtD
Azilsartan medoxomil—Asthenia—Valsartan—coronary artery disease	4.25e-05	0.0016	CcSEcCtD
Azilsartan medoxomil—Asthenia—Olmesartan—coronary artery disease	4.23e-05	0.00159	CcSEcCtD
Azilsartan medoxomil—Rash—Lovastatin—coronary artery disease	4.23e-05	0.00159	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Lovastatin—coronary artery disease	4.22e-05	0.00159	CcSEcCtD
Azilsartan medoxomil—Pruritus—Valsartan—coronary artery disease	4.19e-05	0.00158	CcSEcCtD
Azilsartan medoxomil—Losartan—ACE—coronary artery disease	4.17e-05	0.0477	CrCbGaD
Azilsartan medoxomil—Angioedema—Lisinopril—coronary artery disease	4.17e-05	0.00157	CcSEcCtD
Azilsartan medoxomil—Pruritus—Olmesartan—coronary artery disease	4.17e-05	0.00157	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	4.16e-05	0.00156	CcSEcCtD
Azilsartan medoxomil—Dizziness—Simvastatin—coronary artery disease	4.15e-05	0.00156	CcSEcCtD
Azilsartan medoxomil—Rash—Ezetimibe—coronary artery disease	4.15e-05	0.00156	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Ezetimibe—coronary artery disease	4.14e-05	0.00156	CcSEcCtD
Azilsartan medoxomil—Asthenia—Niacin—coronary artery disease	4.13e-05	0.00155	CcSEcCtD
Azilsartan medoxomil—Fatigue—Losartan—coronary artery disease	4.13e-05	0.00155	CcSEcCtD
Azilsartan medoxomil—Nausea—Fenofibrate—coronary artery disease	4.08e-05	0.00153	CcSEcCtD
Azilsartan medoxomil—Pruritus—Niacin—coronary artery disease	4.07e-05	0.00153	CcSEcCtD
Azilsartan medoxomil—Asthenia—Pravastatin—coronary artery disease	4.07e-05	0.00153	CcSEcCtD
Azilsartan medoxomil—Rash—Eplerenone—coronary artery disease	4.06e-05	0.00153	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Eplerenone—coronary artery disease	4.05e-05	0.00152	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Valsartan—coronary artery disease	4.05e-05	0.00152	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Olmesartan—coronary artery disease	4.03e-05	0.00152	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Ramipril—coronary artery disease	4.03e-05	0.00151	CcSEcCtD
Azilsartan medoxomil—Pruritus—Pravastatin—coronary artery disease	4.01e-05	0.00151	CcSEcCtD
Azilsartan medoxomil—Nausea—Clopidogrel—coronary artery disease	4.01e-05	0.00151	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Ramipril—coronary artery disease	3.99e-05	0.0015	CcSEcCtD
Azilsartan medoxomil—Nausea—Lovastatin—coronary artery disease	3.98e-05	0.0015	CcSEcCtD
Azilsartan medoxomil—Rash—Simvastatin—coronary artery disease	3.95e-05	0.00149	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Simvastatin—coronary artery disease	3.95e-05	0.00149	CcSEcCtD
Azilsartan medoxomil—Asthenia—Trandolapril—coronary artery disease	3.95e-05	0.00149	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Niacin—coronary artery disease	3.94e-05	0.00148	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Timolol—coronary artery disease	3.94e-05	0.00148	CcSEcCtD
Azilsartan medoxomil—Asthenia—Enalapril—coronary artery disease	3.93e-05	0.00148	CcSEcCtD
Azilsartan medoxomil—Dizziness—Valsartan—coronary artery disease	3.92e-05	0.00147	CcSEcCtD
Azilsartan medoxomil—Nausea—Ezetimibe—coronary artery disease	3.91e-05	0.00147	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Timolol—coronary artery disease	3.9e-05	0.00147	CcSEcCtD
Azilsartan medoxomil—Dizziness—Olmesartan—coronary artery disease	3.9e-05	0.00147	CcSEcCtD
Azilsartan medoxomil—Pruritus—Trandolapril—coronary artery disease	3.9e-05	0.00147	CcSEcCtD
Azilsartan medoxomil—Asthenia—Telmisartan—coronary artery disease	3.88e-05	0.00146	CcSEcCtD
Azilsartan medoxomil—Pruritus—Enalapril—coronary artery disease	3.88e-05	0.00146	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Pravastatin—coronary artery disease	3.88e-05	0.00146	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.86e-05	0.00145	CcSEcCtD
Azilsartan medoxomil—Pruritus—Telmisartan—coronary artery disease	3.83e-05	0.00144	CcSEcCtD
Azilsartan medoxomil—Nausea—Eplerenone—coronary artery disease	3.82e-05	0.00144	CcSEcCtD
Azilsartan medoxomil—Dizziness—Niacin—coronary artery disease	3.81e-05	0.00143	CcSEcCtD
Azilsartan medoxomil—Asthenia—Captopril—coronary artery disease	3.77e-05	0.00142	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Trandolapril—coronary artery disease	3.77e-05	0.00142	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Enalapril—coronary artery disease	3.75e-05	0.00141	CcSEcCtD
Azilsartan medoxomil—Dizziness—Pravastatin—coronary artery disease	3.75e-05	0.00141	CcSEcCtD
Azilsartan medoxomil—Rash—Valsartan—coronary artery disease	3.73e-05	0.0014	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Valsartan—coronary artery disease	3.73e-05	0.0014	CcSEcCtD
Azilsartan medoxomil—Nausea—Simvastatin—coronary artery disease	3.72e-05	0.0014	CcSEcCtD
Azilsartan medoxomil—Pruritus—Captopril—coronary artery disease	3.72e-05	0.0014	CcSEcCtD
Azilsartan medoxomil—Rash—Olmesartan—coronary artery disease	3.72e-05	0.0014	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Olmesartan—coronary artery disease	3.71e-05	0.0014	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Telmisartan—coronary artery disease	3.7e-05	0.00139	CcSEcCtD
Azilsartan medoxomil—Asthenia—Perindopril—coronary artery disease	3.66e-05	0.00138	CcSEcCtD
Azilsartan medoxomil—Dizziness—Trandolapril—coronary artery disease	3.64e-05	0.00137	CcSEcCtD
Azilsartan medoxomil—Rash—Niacin—coronary artery disease	3.63e-05	0.00137	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Niacin—coronary artery disease	3.63e-05	0.00136	CcSEcCtD
Azilsartan medoxomil—Dizziness—Enalapril—coronary artery disease	3.63e-05	0.00136	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Lisinopril—coronary artery disease	3.62e-05	0.00136	CcSEcCtD
Azilsartan medoxomil—Pruritus—Perindopril—coronary artery disease	3.61e-05	0.00136	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Captopril—coronary artery disease	3.6e-05	0.00135	CcSEcCtD
Azilsartan medoxomil—Dizziness—Telmisartan—coronary artery disease	3.58e-05	0.00135	CcSEcCtD
Azilsartan medoxomil—Rash—Pravastatin—coronary artery disease	3.57e-05	0.00134	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Pravastatin—coronary artery disease	3.57e-05	0.00134	CcSEcCtD
Azilsartan medoxomil—Asthenia—Furosemide—coronary artery disease	3.56e-05	0.00134	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Ramipril—coronary artery disease	3.55e-05	0.00133	CcSEcCtD
Azilsartan medoxomil—Fatigue—Ramipril—coronary artery disease	3.54e-05	0.00133	CcSEcCtD
Azilsartan medoxomil—Nausea—Valsartan—coronary artery disease	3.52e-05	0.00132	CcSEcCtD
Azilsartan medoxomil—Pruritus—Furosemide—coronary artery disease	3.51e-05	0.00132	CcSEcCtD
Azilsartan medoxomil—Nausea—Olmesartan—coronary artery disease	3.5e-05	0.00132	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Perindopril—coronary artery disease	3.49e-05	0.00131	CcSEcCtD
Azilsartan medoxomil—Dizziness—Captopril—coronary artery disease	3.48e-05	0.00131	CcSEcCtD
Azilsartan medoxomil—Rash—Trandolapril—coronary artery disease	3.47e-05	0.00131	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Trandolapril—coronary artery disease	3.47e-05	0.0013	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Timolol—coronary artery disease	3.47e-05	0.0013	CcSEcCtD
Azilsartan medoxomil—Fatigue—Timolol—coronary artery disease	3.46e-05	0.0013	CcSEcCtD
Azilsartan medoxomil—Rash—Enalapril—coronary artery disease	3.46e-05	0.0013	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Enalapril—coronary artery disease	3.45e-05	0.0013	CcSEcCtD
Azilsartan medoxomil—Asthenia—Losartan—coronary artery disease	3.44e-05	0.00129	CcSEcCtD
Azilsartan medoxomil—Nausea—Niacin—coronary artery disease	3.42e-05	0.00129	CcSEcCtD
Azilsartan medoxomil—Rash—Telmisartan—coronary artery disease	3.41e-05	0.00128	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Telmisartan—coronary artery disease	3.41e-05	0.00128	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Furosemide—coronary artery disease	3.4e-05	0.00128	CcSEcCtD
Azilsartan medoxomil—Pruritus—Losartan—coronary artery disease	3.39e-05	0.00127	CcSEcCtD
Azilsartan medoxomil—Dizziness—Perindopril—coronary artery disease	3.38e-05	0.00127	CcSEcCtD
Azilsartan medoxomil—Nausea—Pravastatin—coronary artery disease	3.37e-05	0.00127	CcSEcCtD
Azilsartan medoxomil—Rash—Captopril—coronary artery disease	3.32e-05	0.00125	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Captopril—coronary artery disease	3.31e-05	0.00125	CcSEcCtD
Azilsartan medoxomil—Dizziness—Furosemide—coronary artery disease	3.28e-05	0.00123	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Losartan—coronary artery disease	3.28e-05	0.00123	CcSEcCtD
Azilsartan medoxomil—Nausea—Trandolapril—coronary artery disease	3.27e-05	0.00123	CcSEcCtD
Azilsartan medoxomil—Nausea—Enalapril—coronary artery disease	3.26e-05	0.00123	CcSEcCtD
Azilsartan medoxomil—Rash—Perindopril—coronary artery disease	3.22e-05	0.00121	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Perindopril—coronary artery disease	3.22e-05	0.00121	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.22e-05	0.00121	CcSEcCtD
Azilsartan medoxomil—Nausea—Telmisartan—coronary artery disease	3.21e-05	0.00121	CcSEcCtD
Azilsartan medoxomil—Fatigue—Lisinopril—coronary artery disease	3.21e-05	0.00121	CcSEcCtD
Azilsartan medoxomil—Dizziness—Losartan—coronary artery disease	3.17e-05	0.00119	CcSEcCtD
Azilsartan medoxomil—Rash—Furosemide—coronary artery disease	3.13e-05	0.00118	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Furosemide—coronary artery disease	3.13e-05	0.00118	CcSEcCtD
Azilsartan medoxomil—Nausea—Captopril—coronary artery disease	3.12e-05	0.00117	CcSEcCtD
Azilsartan medoxomil—Losartan—CYP2C19—coronary artery disease	3.08e-05	0.0352	CrCbGaD
Azilsartan medoxomil—Nausea—Perindopril—coronary artery disease	3.03e-05	0.00114	CcSEcCtD
Azilsartan medoxomil—Rash—Losartan—coronary artery disease	3.02e-05	0.00114	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Losartan—coronary artery disease	3.02e-05	0.00113	CcSEcCtD
Azilsartan medoxomil—Nausea—Furosemide—coronary artery disease	2.95e-05	0.00111	CcSEcCtD
Azilsartan medoxomil—Asthenia—Ramipril—coronary artery disease	2.95e-05	0.00111	CcSEcCtD
Azilsartan medoxomil—Pruritus—Ramipril—coronary artery disease	2.91e-05	0.00109	CcSEcCtD
Azilsartan medoxomil—Asthenia—Timolol—coronary artery disease	2.88e-05	0.00108	CcSEcCtD
Azilsartan medoxomil—Nausea—Losartan—coronary artery disease	2.84e-05	0.00107	CcSEcCtD
Azilsartan medoxomil—Pruritus—Timolol—coronary artery disease	2.84e-05	0.00107	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Ramipril—coronary artery disease	2.81e-05	0.00106	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Timolol—coronary artery disease	2.75e-05	0.00103	CcSEcCtD
Azilsartan medoxomil—Dizziness—Ramipril—coronary artery disease	2.72e-05	0.00102	CcSEcCtD
Azilsartan medoxomil—Asthenia—Lisinopril—coronary artery disease	2.67e-05	0.00101	CcSEcCtD
Azilsartan medoxomil—Dizziness—Timolol—coronary artery disease	2.65e-05	0.000999	CcSEcCtD
Azilsartan medoxomil—Pruritus—Lisinopril—coronary artery disease	2.64e-05	0.000991	CcSEcCtD
Azilsartan medoxomil—Rash—Ramipril—coronary artery disease	2.59e-05	0.000974	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Ramipril—coronary artery disease	2.59e-05	0.000973	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Lisinopril—coronary artery disease	2.55e-05	0.000958	CcSEcCtD
Azilsartan medoxomil—Rash—Timolol—coronary artery disease	2.53e-05	0.000952	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Timolol—coronary artery disease	2.53e-05	0.000951	CcSEcCtD
Azilsartan medoxomil—Dizziness—Lisinopril—coronary artery disease	2.46e-05	0.000926	CcSEcCtD
Azilsartan medoxomil—Nausea—Ramipril—coronary artery disease	2.44e-05	0.000917	CcSEcCtD
Azilsartan medoxomil—Nausea—Timolol—coronary artery disease	2.38e-05	0.000897	CcSEcCtD
Azilsartan medoxomil—Rash—Lisinopril—coronary artery disease	2.35e-05	0.000883	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Lisinopril—coronary artery disease	2.35e-05	0.000882	CcSEcCtD
Azilsartan medoxomil—Nausea—Lisinopril—coronary artery disease	2.21e-05	0.000832	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR7—coronary artery disease	1.85e-05	0.00107	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—coronary artery disease	1.84e-05	0.00106	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—coronary artery disease	1.79e-05	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PPBP—coronary artery disease	1.79e-05	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—KNG1—coronary artery disease	1.76e-05	0.00102	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AVPR1A—coronary artery disease	1.74e-05	0.001	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADM2—coronary artery disease	1.73e-05	0.001	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL10—coronary artery disease	1.71e-05	0.000987	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—OPRD1—coronary artery disease	1.71e-05	0.000987	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL4—coronary artery disease	1.71e-05	0.000987	CbGpPWpGaD
Azilsartan medoxomil—Losartan—ALB—coronary artery disease	1.71e-05	0.0196	CrCbGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—coronary artery disease	1.71e-05	0.000984	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—coronary artery disease	1.7e-05	0.000982	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—UTS2—coronary artery disease	1.68e-05	0.000968	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—ADRB2—coronary artery disease	1.66e-05	0.000958	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TMED2—coronary artery disease	1.64e-05	0.000948	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PLCB3—coronary artery disease	1.63e-05	0.000938	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—P2RY12—coronary artery disease	1.63e-05	0.000938	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—coronary artery disease	1.62e-05	0.000933	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CASR—coronary artery disease	1.61e-05	0.000928	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AVPR1A—coronary artery disease	1.58e-05	0.000911	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—BDKRB1—coronary artery disease	1.58e-05	0.00091	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—GNA12—coronary artery disease	1.58e-05	0.00091	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL8—coronary artery disease	1.57e-05	0.000906	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RLN3—coronary artery disease	1.57e-05	0.000904	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LRP8—coronary artery disease	1.57e-05	0.000904	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DGKZ—coronary artery disease	1.57e-05	0.000904	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—coronary artery disease	1.56e-05	0.000899	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADM—coronary artery disease	1.54e-05	0.000886	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—UTS2—coronary artery disease	1.52e-05	0.000879	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AES—coronary artery disease	1.5e-05	0.000867	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EDN2—coronary artery disease	1.5e-05	0.000867	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PDE4B—coronary artery disease	1.5e-05	0.000863	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—coronary artery disease	1.5e-05	0.000862	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—EDN1—coronary artery disease	1.48e-05	0.000856	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PLCB3—coronary artery disease	1.48e-05	0.000852	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—P2RY12—coronary artery disease	1.48e-05	0.000852	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL5—coronary artery disease	1.47e-05	0.00085	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CX3CR1—coronary artery disease	1.46e-05	0.000843	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CASR—coronary artery disease	1.46e-05	0.000843	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HRH2—coronary artery disease	1.45e-05	0.000835	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—GNA12—coronary artery disease	1.43e-05	0.000827	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—BDKRB1—coronary artery disease	1.43e-05	0.000827	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CX3CL1—coronary artery disease	1.43e-05	0.000827	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PPP3R1—coronary artery disease	1.41e-05	0.000812	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADM—coronary artery disease	1.39e-05	0.000804	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR3—coronary artery disease	1.37e-05	0.000789	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—coronary artery disease	1.36e-05	0.000786	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PDE4B—coronary artery disease	1.36e-05	0.000784	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—coronary artery disease	1.33e-05	0.000769	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RHOC—coronary artery disease	1.31e-05	0.000758	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ACVR1B—coronary artery disease	1.31e-05	0.000758	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR2A—coronary artery disease	1.3e-05	0.000749	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—C3—coronary artery disease	1.3e-05	0.000748	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL2—coronary artery disease	1.29e-05	0.000742	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NEDD4—coronary artery disease	1.28e-05	0.000737	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—F2R—coronary artery disease	1.27e-05	0.000734	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MDK—coronary artery disease	1.25e-05	0.000719	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDE3A—coronary artery disease	1.25e-05	0.000719	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RAMP2—coronary artery disease	1.25e-05	0.000719	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PF4—coronary artery disease	1.25e-05	0.000719	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR3—coronary artery disease	1.24e-05	0.000717	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—EDNRB—coronary artery disease	1.23e-05	0.000711	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—AGT—coronary artery disease	1.23e-05	0.000711	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RALBP1—coronary artery disease	1.19e-05	0.000685	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY5R—coronary artery disease	1.19e-05	0.000685	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—F2RL1—coronary artery disease	1.19e-05	0.000685	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL2—coronary artery disease	1.17e-05	0.000674	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL3—coronary artery disease	1.17e-05	0.000674	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—EDNRA—coronary artery disease	1.16e-05	0.000671	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADRB1—coronary artery disease	1.16e-05	0.000668	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—F2R—coronary artery disease	1.16e-05	0.000666	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FZD2—coronary artery disease	1.14e-05	0.000657	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—UTS2R—coronary artery disease	1.14e-05	0.000657	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—F2—coronary artery disease	1.14e-05	0.000657	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—EDNRB—coronary artery disease	1.12e-05	0.000645	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SFRP2—coronary artery disease	1.12e-05	0.000644	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADORA3—coronary artery disease	1.1e-05	0.000633	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADORA1—coronary artery disease	1.1e-05	0.000633	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOA4—coronary artery disease	1.1e-05	0.000633	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL12—coronary artery disease	1.09e-05	0.000631	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—BDKRB2—coronary artery disease	1.09e-05	0.000631	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PLCB1—coronary artery disease	1.07e-05	0.000617	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PGF—coronary artery disease	1.06e-05	0.000611	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PPBP—coronary artery disease	1.06e-05	0.000611	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—EDNRA—coronary artery disease	1.06e-05	0.00061	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	1.05e-05	0.000608	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADRB1—coronary artery disease	1.05e-05	0.000607	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR7—coronary artery disease	1.05e-05	0.000604	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DVL1—coronary artery disease	1.04e-05	0.000601	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ITGA2B—coronary artery disease	1.04e-05	0.000601	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—coronary artery disease	1.04e-05	0.0006	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—POMC—coronary artery disease	1.04e-05	0.000598	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL2—coronary artery disease	1.01e-05	0.000585	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL4—coronary artery disease	1.01e-05	0.000583	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GHR—coronary artery disease	1.01e-05	0.000583	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—OPRD1—coronary artery disease	1.01e-05	0.000583	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—PIK3CA—coronary artery disease	1.01e-05	0.000582	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—KNG1—coronary artery disease	9.96e-06	0.000574	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—BDKRB2—coronary artery disease	9.94e-06	0.000573	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL12—coronary artery disease	9.94e-06	0.000573	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PLCB1—coronary artery disease	9.72e-06	0.000561	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MEF2A—coronary artery disease	9.69e-06	0.000559	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TLE4—coronary artery disease	9.69e-06	0.000559	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL10—coronary artery disease	9.67e-06	0.000558	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR7—coronary artery disease	9.52e-06	0.000549	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOA2—coronary artery disease	9.44e-06	0.000545	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADRB2—coronary artery disease	9.39e-06	0.000541	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AVPR1A—coronary artery disease	9.33e-06	0.000538	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PRKCE—coronary artery disease	9.27e-06	0.000535	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—KNG1—coronary artery disease	9.04e-06	0.000521	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—coronary artery disease	9.03e-06	0.000521	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—UTS2—coronary artery disease	9.01e-06	0.000519	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NR4A1—coronary artery disease	8.82e-06	0.000508	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL10—coronary artery disease	8.78e-06	0.000506	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—P2RY12—coronary artery disease	8.72e-06	0.000503	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLCB3—coronary artery disease	8.72e-06	0.000503	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HDAC9—coronary artery disease	8.72e-06	0.000503	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CX3CR1—coronary artery disease	8.64e-06	0.000498	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CASR—coronary artery disease	8.64e-06	0.000498	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADRB2—coronary artery disease	8.53e-06	0.000492	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CX3CL1—coronary artery disease	8.47e-06	0.000488	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GNA12—coronary artery disease	8.47e-06	0.000488	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BDKRB1—coronary artery disease	8.47e-06	0.000488	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—P4HB—coronary artery disease	8.47e-06	0.000488	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PRKCE—coronary artery disease	8.42e-06	0.000485	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—EDN1—coronary artery disease	8.39e-06	0.000484	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCL5—coronary artery disease	8.33e-06	0.00048	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PPP3R1—coronary artery disease	8.31e-06	0.000479	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADM—coronary artery disease	8.24e-06	0.000475	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CSF2—coronary artery disease	8.2e-06	0.000473	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDE4B—coronary artery disease	8.03e-06	0.000463	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CYBB—coronary artery disease	8.03e-06	0.000463	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL8—coronary artery disease	8.02e-06	0.000463	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—MMP3—coronary artery disease	8.01e-06	0.000462	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—coronary artery disease	7.99e-06	0.000461	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—EDN1—coronary artery disease	7.62e-06	0.000439	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL5—coronary artery disease	7.56e-06	0.000436	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PRKCD—coronary artery disease	7.5e-06	0.000433	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CSF2—coronary artery disease	7.45e-06	0.000429	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR3—coronary artery disease	7.34e-06	0.000423	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR2A—coronary artery disease	7.34e-06	0.000423	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C3—coronary artery disease	7.33e-06	0.000423	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CRK—coronary artery disease	7.25e-06	0.000418	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SH2B3—coronary artery disease	7.16e-06	0.000413	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ATP2A2—coronary artery disease	7.16e-06	0.000413	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—VWF—coronary artery disease	7.16e-06	0.000413	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOC3—coronary artery disease	7.11e-06	0.00041	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LDLR—coronary artery disease	7.07e-06	0.000408	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AGT—coronary artery disease	6.96e-06	0.000402	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PPP2CA—coronary artery disease	6.94e-06	0.0004	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL2—coronary artery disease	6.9e-06	0.000398	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL3—coronary artery disease	6.9e-06	0.000398	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—F2R—coronary artery disease	6.83e-06	0.000394	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SDC1—coronary artery disease	6.83e-06	0.000394	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PRKCD—coronary artery disease	6.81e-06	0.000393	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FGB—coronary artery disease	6.68e-06	0.000385	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR2A—coronary artery disease	6.67e-06	0.000384	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C3—coronary artery disease	6.66e-06	0.000384	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EDNRB—coronary artery disease	6.61e-06	0.000381	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—THBS1—coronary artery disease	6.51e-06	0.000376	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PSMA6—coronary artery disease	6.45e-06	0.000372	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PSMB5—coronary artery disease	6.45e-06	0.000372	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—F2—coronary artery disease	6.44e-06	0.000371	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AGT—coronary artery disease	6.32e-06	0.000365	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EDNRA—coronary artery disease	6.24e-06	0.00036	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CYBA—coronary artery disease	6.22e-06	0.000358	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADRB1—coronary artery disease	6.22e-06	0.000358	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DUSP6—coronary artery disease	6.19e-06	0.000357	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLAT—coronary artery disease	6.09e-06	0.000351	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BDKRB2—coronary artery disease	5.87e-06	0.000339	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL12—coronary artery disease	5.87e-06	0.000339	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—POMC—coronary artery disease	5.86e-06	0.000338	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—F2—coronary artery disease	5.84e-06	0.000337	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6ST—coronary artery disease	5.82e-06	0.000336	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—JUNB—coronary artery disease	5.76e-06	0.000332	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLCB1—coronary artery disease	5.74e-06	0.000331	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR7—coronary artery disease	5.62e-06	0.000324	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ITGAV—coronary artery disease	5.36e-06	0.000309	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KNG1—coronary artery disease	5.34e-06	0.000308	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CREB1—coronary artery disease	5.32e-06	0.000307	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—POMC—coronary artery disease	5.32e-06	0.000307	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL2—coronary artery disease	5.21e-06	0.0003	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6R—coronary artery disease	5.19e-06	0.000299	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL10—coronary artery disease	5.19e-06	0.000299	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLG—coronary artery disease	5.17e-06	0.000298	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADRB2—coronary artery disease	5.04e-06	0.00029	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKCE—coronary artery disease	4.97e-06	0.000287	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—JAK2—coronary artery disease	4.97e-06	0.000287	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SOCS1—coronary artery disease	4.96e-06	0.000286	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—S100B—coronary artery disease	4.95e-06	0.000285	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SOCS3—coronary artery disease	4.9e-06	0.000283	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KITLG—coronary artery disease	4.84e-06	0.000279	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TGFBR2—coronary artery disease	4.84e-06	0.000279	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP3—coronary artery disease	4.73e-06	0.000273	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—STAT5A—coronary artery disease	4.73e-06	0.000273	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOB—coronary artery disease	4.57e-06	0.000264	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL8—coronary artery disease	4.53e-06	0.000262	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—JAK2—coronary artery disease	4.51e-06	0.00026	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EDN1—coronary artery disease	4.5e-06	0.00026	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL5—coronary artery disease	4.47e-06	0.000258	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CSF2—coronary artery disease	4.4e-06	0.000254	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FGF1—coronary artery disease	4.4e-06	0.000254	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LPL—coronary artery disease	4.37e-06	0.000252	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MEF2C—coronary artery disease	4.33e-06	0.00025	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RPS6KB1—coronary artery disease	4.33e-06	0.00025	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ITGB3—coronary artery disease	4.22e-06	0.000243	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL8—coronary artery disease	4.12e-06	0.000237	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PPP2CA—coronary artery disease	4.1e-06	0.000236	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKCD—coronary artery disease	4.02e-06	0.000232	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR2A—coronary artery disease	3.94e-06	0.000227	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C3—coronary artery disease	3.93e-06	0.000227	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HIF1A—coronary artery disease	3.75e-06	0.000216	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AGT—coronary artery disease	3.74e-06	0.000215	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LEP—coronary artery disease	3.66e-06	0.000211	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOE—coronary artery disease	3.66e-06	0.000211	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOA1—coronary artery disease	3.62e-06	0.000209	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KDR—coronary artery disease	3.59e-06	0.000207	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MAPK14—coronary artery disease	3.56e-06	0.000205	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ESR1—coronary artery disease	3.5e-06	0.000202	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—F2—coronary artery disease	3.45e-06	0.000199	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FN1—coronary artery disease	3.45e-06	0.000199	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6ST—coronary artery disease	3.44e-06	0.000198	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NFKBIA—coronary artery disease	3.41e-06	0.000197	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KIT—coronary artery disease	3.3e-06	0.000191	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GSK3B—coronary artery disease	3.17e-06	0.000183	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—POMC—coronary artery disease	3.14e-06	0.000181	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CREB1—coronary artery disease	3.14e-06	0.000181	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL2—coronary artery disease	3.08e-06	0.000177	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6R—coronary artery disease	3.07e-06	0.000177	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IGF1—coronary artery disease	3.02e-06	0.000174	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—MAPK1—coronary artery disease	3.01e-06	0.000174	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.88e-06	0.000166	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SERPINE1—coronary artery disease	2.87e-06	0.000166	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FGF2—coronary artery disease	2.78e-06	0.00016	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOS3—coronary artery disease	2.74e-06	0.000158	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—JAK2—coronary artery disease	2.67e-06	0.000154	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3CA—coronary artery disease	2.61e-06	0.000151	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL8—coronary artery disease	2.43e-06	0.00014	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AKT1—coronary artery disease	2.35e-06	0.000136	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CASP3—coronary artery disease	2.33e-06	0.000134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6—coronary artery disease	2.31e-06	0.000133	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCND1—coronary artery disease	2.27e-06	0.000131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP9—coronary artery disease	2.2e-06	0.000127	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AKT1—coronary artery disease	2.13e-06	0.000123	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—VEGFA—coronary artery disease	1.98e-06	0.000114	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TGFB1—coronary artery disease	1.81e-06	0.000105	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MAPK1—coronary artery disease	1.78e-06	0.000103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3CA—coronary artery disease	1.54e-06	8.9e-05	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6—coronary artery disease	1.37e-06	7.88e-05	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKT1—coronary artery disease	1.26e-06	7.27e-05	CbGpPWpGaD
